We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Some Patients Can Discontinue Hypertension Drugs

By HospiMedica staff writers
Posted on 08 Mar 2001
Forty-two percent of patients whose hypertension medicine was discontinued were likely to maintain normal blood pressure for more than a year, according to a study in the February issue of the American Journal of Hypertension, a publication of the American Society of Hypertension. More...
The study was conducted by researchers at Alfred Hospital (Prahran, Australia).

The investigators noted that some doctors have difficulty in selecting patients for medication withdrawal and have concerns about patient safety and legal liability. Those most likely to be successfully withdrawn from medication are those with mildly elevated uncomplicated blood pressure that has been controlled by one medication. Patients must be carefully screened before they are selected and must be motivated and willing to accept lifestyle changes if needed.

The recommendations were based on an analysis of 12 major studies focusing on the withdrawal of antihypertensive therapy since the 1950s. When therapy is withdrawn, it is crucial, said the researchers, to start and continue long-term monitoring of patients in order to detect any return of high blood pressure. They speculate that most patients for whom withdrawal is appropriate may be those in whom therapy was commenced inappropriately. Because of this, it is important to confirm the diagnosis before starting treatment.

The U.S. Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure recommends that a decision to treat mild-to-moderate blood pressure elevation should be based on at least two blood pressure readings on at least three separate occasions.



Related Links:
American Society of Hypertension

Gold Member
12-Channel ECG
CM1200B
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Surgical System
Stealth AXiS
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.